OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert MRNA.../  DE000ME6QFS3  /

Stuttgart
2024-05-27  9:50:56 PM Chg.-0.08 Bid10:00:32 PM Ask10:00:32 PM Underlying Strike price Expiration date Option type
113.91EUR -0.07% -
Bid Size: -		 -
Ask Size: -		 Moderna Inc - USD 2024-09-27 Call
GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-22 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
TeleTrader 05-20 Dow slumps 195 points at closing bell after corporate news
GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants
TeleTrader 05-13 Wall Street closes mixed ahead of key inflation data
GlobeNewswire 05-12 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 05-02 US surges at close as traders weigh Fed remarks
TeleTrader 05-02 Moderna surges 9% as Q1 revenue beat expectations
GlobeNewswire 05-02 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 05-02 Moderna sees $167M in Q1 revenue, beats forecasts
TeleTrader 05-02 US higher premarket after Fed's decision
GlobeNewswire 05-01 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
TeleTrader 04-24 Moderna, OpenAI partner on mRNA medicine advancement
TeleTrader 04-09 US markets close mostly higher ahead of inflation report
GlobeNewswire 04-04 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
TeleTrader 03-28 US closes mixed amid data
TeleTrader 03-26 Wall Street closes lower after economic data
GlobeNewswire 03-21 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-11 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire 03-04 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire 02-29 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire 02-27 CytomX Therapeutics to Present at Upcoming March Investor Conferences